Gerald Lelais

Gerald Lelais currently serves as the Executive Director of Medicinal Chemistry at Genesis Therapeutics, a position held since September 2025. Prior to this role, Gerald was the Executive Director at Odyssey Therapeutics from November 2021 to August 2025. Gerald's extensive experience includes a significant tenure at GNF from October 2006 to December 2021, where responsibilities included roles as Associate Director and various research investigator positions, contributing to the Hit-to-Lead and Lead Optimization processes for multiple GPCR and kinase projects. Academic qualifications include a Postdoctoral Research Fellowship in Chemistry from Caltech (2004-2006), a Ph.D. in Chemistry from ETH Zürich (2000-2004), and a B.S. in Chemistry from ETH Zürich (1995-2000).